Ferring activates first sites in a three-arm study of ADSTILADRIN as a monotherapy or in combination with chemotherapy or an ...

The US Food and Drug Administration (FDA) has approved Swiss drugmaker Ferring Pharmaceuticals’ Adstiladrin (nadofaragene firedenovec-vncg) for the treatment of adult patients with high-risk ...

Ferring Pharmaceuticals today announced it has advanced three studies in the ADSTILADRIN ® (nadofaragene firadenovec-vncg) clinical trial program – two studies in patients with non-muscle ...